Organon & Co.
OGN
$8.18
-$0.265-3.14%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.84% | 2.24% | 4.21% | 2.89% | 3.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.84% | 2.24% | 4.21% | 2.89% | 3.29% |
| Cost of Revenue | 3.65% | 6.88% | 10.67% | 11.54% | 12.85% |
| Gross Profit | -3.95% | -0.88% | 0.03% | -2.47% | -2.45% |
| SG&A Expenses | -3.32% | -2.93% | -11.36% | -0.06% | 2.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.47% | 1.26% | -0.41% | 5.22% | 7.52% |
| Operating Income | -2.10% | 5.61% | 21.38% | -4.42% | -9.04% |
| Income Before Tax | -0.30% | 19.91% | 15.00% | -25.74% | -26.34% |
| Income Tax Expenses | 79.09% | 83.71% | -646.32% | -369.53% | -320.71% |
| Earnings from Continuing Operations | -28.37% | -15.54% | 122.39% | 32.63% | 40.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.37% | -15.54% | 122.39% | 32.63% | 40.35% |
| EBIT | -2.10% | 5.61% | 21.38% | -4.42% | -9.04% |
| EBITDA | 1.32% | 7.29% | 20.29% | -2.21% | -6.38% |
| EPS Basic | -28.91% | -16.11% | 121.09% | 31.96% | 39.63% |
| Normalized Basic EPS | 0.40% | 12.22% | 41.70% | -10.62% | -21.05% |
| EPS Diluted | -29.67% | -16.81% | 120.46% | 31.77% | 39.79% |
| Normalized Diluted EPS | 0.09% | 11.78% | 41.31% | -10.83% | -21.12% |
| Average Basic Shares Outstanding | 0.79% | 0.71% | 0.63% | 0.56% | 0.50% |
| Average Diluted Shares Outstanding | 1.17% | 1.13% | 0.92% | 0.72% | 0.54% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.43% | 0.20% | -0.55% | -0.24% | -0.29% |